Stay updated on Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2 label. This change updates the page's revision history or UI without affecting core study information.SummaryDifference0.1%

- Check17 days agoChange DetectedA new revision number (v3.6.2) appears on the page as part of a small update, indicating lightweight maintenance with no apparent changes to the study information.SummaryDifference0.1%

- Check31 days agoChange DetectedRecruitment status is updated to not recruiting, and new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, while the Intervention/Treatment label was updated and an older revision note (v3.5.5) was replaced with v3.6.0.SummaryDifference0.5%

- Check38 days agoChange DetectedA new revision label v3.5.5 was added to the page's revision history, and the previous label v3.5.4 was removed, indicating a minor update to the revision history without altering study information.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 on the page indicates a newer version of the document. This reflects minor updates or corrections without altering the core study content or conclusions presented to users.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page shows an update to the site’s software/UI revision from v3.5.0 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenalidomide in Lymphoma Clinical Trial page.